No insider purchase over the last 90 days. The latest, by Martin Richardson, was filed 29 May 2026.
Stille AB belongs to the Health Care sector. Filings by its managers are published through Finansinspektionen. Over the twelve months to 24 October 2026, 16 filings were filed, from 7 insiders.
Purchases and sales both appear in the filings: 12 purchases (5 insiders, €541k) and 4 sales (3 insiders, €356k). The net balance comes to €185k on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 3 board members, 1 senior executive and 1 chief executive among the declarants. At €186k, the sale published on 30 April 2026 by Markus Spingler is the largest of the period.
In all, 7 purchases were made within 30 days of a purchase by another insider of the company. Purchases made close together by different insiders form what is called a cluster. The most recent open-market purchase was published on 29 May 2026, 148 days ago. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade.
Compared with its exchange (1,028 companies, median 9 filings), a count of 16 filings is above the norm. The full history, which starts in 2016, counts 19 purchases against 13 sales.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Stille AB Buy (bullish), based on 2 analysts. Average price target: SEK 287.00.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 33 declarations
Stille AB is a company focused on the development and manufacturing of surgical instruments. It is listed on the Stockholm Stock Exchange (XSTO).
Purchases our model currently ranks for the recommendations list.
All recommendations